Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02478775 · ClinicalTrials.gov registry record · NA
Dysregulation of FSH in Obesity: Functional and Statistical Analysis
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT02478775 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 99 participants.
The verdict
NCT02478775, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
Excess maternal weight, especially obesity, influences almost every aspect of fertility, from conception to problems during pregnancy. The investigators will use novel statistical methods to clarify the hormonal changes behind reproductive health conditions. A better understanding of reproductive hormonal changes in obese women may offer a way to identify new treatments.
Interventions
- DRUG recombinant FSH
- DRUG Cetrorelix
- DRUG Degarelix (GnRH antagonist)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2015-07 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02478775
The ClinicalTrials.gov registry entry for NCT02478775 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which recombinant FSH is the first listed.
NCT02478775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02478775 about?
NCT02478775 is a clinical study titled "Dysregulation of FSH in Obesity: Functional and Statistical Analysis". Excess maternal weight, especially obesity, influences almost every aspect of fertility, from conception to problems during pregnancy. The investigators will use novel statistical methods to clarify the hormonal changes behind reproductive health conditions. A better understanding of reproductive ho...
What is the current status of trial NCT02478775?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2015-07. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT02478775?
The interventions under investigation include: recombinant FSH (DRUG), Cetrorelix (DRUG), Degarelix (GnRH antagonist) (DRUG).
Who is sponsoring clinical trial NCT02478775?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.